A commonly used blood pressure drug has been recalled over concerns it could be cross-contaminated with another drug.
Glenmark Pharmaceuticals Inc. has recalled more than 11,100 bottles of bisoprolol fumarate and hydrochlorothiazide tablets under the brand name Ziac because the tablets may be cross-contaminated with other products. This is evident from a recall published by the Food and Drug Administration.
Bisoprolol/hydrochlorothiazide is often used to treat high blood pressure, also called hypertension, by blocking the beta-1 receptors in the heart and causing the heart to beat regularly. according to WebMD.
The recall notice stated that testing of backup samples “demonstrated the presence of ezetimibe,” a drug used to treat high cholesterol.
The December 1 recall was listed as Class III, meaning use or exposure to the product is “not likely to cause adverse health effects.” the FDA said.
The affected pills are available in 2.5 mg and 6.25 mg doses, according to the agency.
Specific affected packages include 30-count bottles of NDC-68462-878-30, 100-count bottles of NDC-68462-878-01 and 500-count bottles of NDC-68462-878-05, according to the recall.
The affected lot numbers have an expiration date of November 2025 to May 2026.
A total of 11,136 bottles were involved in the recall.
The FDA has not said what patients should do if their medications are affected by the recall.
The independent has contacted the FDA and Glenmark Pharmaceuticals for comment.
#recalling #popular #blood #pressure #medications #fears #drug #crosscontamination